The term microbiome is a portmanteau of microbiota (the microbial community) and genome. It refers to both the microorganisms found in a specific environment and all of their genetic information. The human microbiome describes the ecosystem of trillions of microbes residing within the human body. It plays a critical role in the onset, progression, and severity of various diseases—including metabolic disorders (e.g., diabetes, obesity), autoimmune diseases (e.g., psoriasis, allergies, inflammatory bowel disease), and neurological disorders (e.g., depression, autism).
| Classification | Indicator |
|---|---|
| Number of microorganisms | Approx. 39 trillion microbes in the human body |
| Percentage of microorganisms | 95% of the microbes in the digestive system |
| Genes in gut bacteria | 150 times more bacterial genes in the gut than human genes |
| Body weight ratio | Microbiome accounts for 1-3% of body weight |
*Source: Planning Report for the Hospital-based Human Microbiome R&D Project (KHIDI)
Although the microbiome accounts for only 1-3% of body weight, it plays a vital role in the human body by influencing nutrient absorption, drug metabolism, immune regulation, and neurodevelopment.
| Function | Description |
|---|---|
| Nutrient Absorption | Variation in nutrient absorption based on microbiome composition (even with identical nutrient intake) |
| Drug Metabolism Regulation | Protection from harmful substances (e.g., drugs and carcinogens) |
| Immune Regulation | Immune-mediated defense against pathogenic microbes |
| Neurodevelopment | Influence of microbial metabolites on brain development and behavior regulation |
*Source: Planning Report for the Hospital-based Human Microbiome R&D Project (KHIDI)
The microbiome market: Health functional products, therapeutic development, and diagnositc tools and services.
| Category | Description |
|---|---|
| Functional Products | Products employing probiotics and prebiotics for gut microbiota balance and functional enhancement (e.g., dietary supplements, cosmetics). |
| Therapeutics Development | Therapeutic development based on the correlation between the gut microbiome and various diseases (covering fields from gastrointestinal disorders to cancer, obesity, diabetes, oral diseases, hepatitis, and skin conditions) |
| Diagnostics & Services | Diagnostic marker development using disease-specific imbalances in gut microbiome composition (i.e., differences in the balance between commensal and harmful bacteria in patients versus healthy individuals) |